Hepatocellular carcinoma (HCC) remains highly fatal due to late diagnosis and scarce early biomarkers. Multi‑omics and liquid biopsy advances improve early detection, prognostication, and monitoring.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results